Comparing severe outcome risks of SARS-CoV-2 Omicron BA.2.75, BQ.1, BA.4.6 to BA.5

FHS
July 20, 2023
3:26 pm

Researchers determine the clinical severity of SARS-CoV-2 Omicron sub-lineages BA.4.6, BQ.1, and BA.2.75 relative to BA.5.

atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine) – Psychedelic Alpha

Advanced multiple clinical stage assets in development, including the on-going Phase 2b study of RL-007 in patients with Cognitive Impairment Associated with Schizophrenia DMX-1002 (Ibogaine)

August 10, 2023

Walensky prepares to leave CDC — and Congress — after a bruising 29 months

Rochelle Walensky, the outgoing director of the Centers for Disease Control and Prevention, will miss aspects of leading the nation’s top public health agency when

June 29, 2023

Low-Dose Aspirin in Pregnancy Doesn’t Impact Kids’ Brain Development

Early antenatal exposure to low-dose aspirin neither worsened nor improved kids’ neurodevelopment, according to a follow-up study to the multinational ASPIRIN trial. Bayley Scales of

January 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.